The specificity of targeting and the high tumor uptake make our developed anti-MUC16 antibody a great contrast agent for non-invasive imaging and show potential for further development as radiopharmaceuticals for targeted therapy of MUC16-expressing cancers. This evidence concerns the gene MUC16 and cancer.